Close
CDMO Safety Testing 2026
Novotech

Bora Pharmaceutical makes strategic appointment to strengthen global manufacturing capabilities

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Teva Adds Ecopipam Therapy in $700M Emalex Acquisition Deal

Teva Pharmaceuticals has entered into a definitive agreement to...

BIO Asia – Taiwan 2026 to be Held in Mid-July in Taipei

Focusing on AI Integration to Unlock Opportunities for Accelerating...
- Advertisement -

Bora Pharmaceuticals, a full-service contract development andย manufacturing organization (CDMO), has appointed Don Liscombe as their Vice President andย General Manager to lead its flagship manufacturing facility in North America, located in Mississauga,ย  Ontario, Canada.

Don will be responsible for leading the ambitious growth plans for the Mississauga facility and itsย  current 400 strong workforce. Bringing a wealth of experience in pharmaceutical operations and theย  contract manufacturing industry, Don is recognized for driving profitable growth through customerย  service, employee engagement and a commitment to operational excellence. He has heldย  progressively senior roles in the industry, including General Manager and most recently as leader ofย  Regional Operational excellence at a global CDMO.

Commenting on his appointment, Don Liscombe said โ€œI am privileged to serve in an industry thatย  has a profound impact on peopleโ€™s lives, and I am honoured to join the Bora team whose mission isย  โ€œContributing to Better Health All Over the Worldโ€.

โ€œI am impressed by the companyโ€™s track record of delivering top-tier services to their customers andย  I am truly excited to be joining them at a time of significant growth to reach more patient around theย  worldโ€.

Bobby Sheng, CEO of Bora Pharmaceuticals commented; โ€œwe are delighted to be in a position toย  attract a leader like Don into the organization, he brings invaluable CDMO knowledge andย  experience to the team, and will help drive us towards our impressive growth strategy.

Latest stories

Related stories

Teva Adds Ecopipam Therapy in $700M Emalex Acquisition Deal

Teva Pharmaceuticals has entered into a definitive agreement to...

BIO Asia – Taiwan 2026 to be Held in Mid-July in Taipei

Focusing on AI Integration to Unlock Opportunities for Accelerating...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป